Century Therapeutics, Inc.

Healthcare

NASDAQ:IPSC · NASDAQ Global Select

Market Cap $197.38M Beta 1.57 P/E (TTM) -1.8

$2.29 +0.48%

+$0.01 today

52W Low $0.44High $3.04

Vol 0.57M · Avg 1.12M

EPS (TTM) -$1.25Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+298.26%

Period High

$2.94

Period Low

$0.46

Latest

$2.29

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Karyopharm Therapeutics Inc.

NASDAQ:KPTI

$206.69M

Equillium, Inc.

NASDAQ:EQ

$107.81M

OS Therapies Incorporated

AMEX:OSTX

$80.84M

Cue Biopharma, Inc.

NASDAQ:CUE

$71.77M

Outlook Therapeutics, Inc.

NASDAQ:OTLK

$63.36M

Coeptis Therapeutics, Inc.

NASDAQ:COEP

$55.98M

Telomir Pharmaceuticals, Inc. Common Stock

TELO

$45.90M

Genenta Science S.p.A.

GNTA

$32.55M

Senti Biosciences, Inc.

SNTI

$24.58M

Medicus Pharma Ltd. Common Stock

MDCX

$9.46M

What is the latest IPSC filing?

The latest filing shown is 8-K dated Jun 16, 2026.

How many recent filings does IPSC have?

Intrinsic Alpha currently shows 20 recent filings for IPSC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.